Efficacy and Safety Between Tegileridine and Sufentanil in Laparoscopic Surgery Patients at High Risk of Postoperative Nausea and Vomiting

Navigating NSAID safety in early pregnancy: Challenges in interpreting congenital malformation risk

This Perspective article by Yuen and Man discusses the challenges of interpreting research on NSAID safety during early pregnancy, particula

https://www.cell.com/cell/fulltext/S0092-8674(26)00287-4

FDA Approves First Non-Opioid Pain Reliever: Journavx by Vertex Pharmaceuticals

The FDA approved Vertex Pharmaceuticals's Journavx (suzetrigine) in January 2025, marking the first non-opioid pain reliever.

Neurologists reassess dopamine agonists as first-line Parkinson's treatment amid impulse control concerns

Dopamine agonists like pramipexole, ropinirole, rotigotine, and apomorphine have traditionally been recommended as first-line therapy for yo

Study Links Antidepressants and Antidiarrheal Drugs to Slightly Higher Mortality Risk in IBS Patients

A study published in Communications Medicine found that antidepressants and certain antidiarrheal drugs (mu receptor agonists like loperamid

Experts warn easy access to GLP-1 drugs may increase eating disorder risks

Experts are raising concerns that the widespread availability of GLP-1 drugs (like Ozempic and Wegovy) through telemedicine and oral formula